跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 136 条关于
“VIVID WORKSTATION”
全部
136
临床试验
61
药物
8
机构
18
资讯
49
去年
Scientific Industries Launches DOTS MPS for Cell Culture Biopharma Market, Reports 24% Bioprocessing Revenue Growth
上个月
Vivid Dx Raises $15M Seed Funding to Advance AI-Powered Rapid Diagnostics for Drug-Resistant Infections
去年
FDA Approves Lilly's Omvoh (mirikizumab) for Crohn's Disease
去年
IMU Biosciences Partners with Curiox for UK's Largest Immune Profiling Initiative
2年前
Star Therapeutics' VGA039 Shows Promise as Subcutaneous VWD Therapy
去年
Lilly's Omvoh Demonstrates Superior Histological Response Over Stelara in Crohn's Disease Trial
去年
Mirikizumab Shows Sustained Remission in Crohn's Disease and Ulcerative Colitis
去年
Lilly's Omvoh Nears EU Approval for Crohn's Disease After Positive CHMP Opinion
去年
J&J's Tremfya and Lilly's Omvoh Demonstrate Efficacy in Crohn's Disease Phase III Trials
去年
Mirikizumab Shows Superior Histologic Response Compared to Ustekinumab in Crohn's Disease
第 1 页,共 5 页
上一页
下一页